Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1652

1.

The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.

Jeong CW, Washington SL 3rd, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR.

Eur Urol. 2020 Jan 21. pii: S0302-2838(20)30045-2. doi: 10.1016/j.eururo.2020.01.009. [Epub ahead of print]

PMID:
31980309
2.

Reply by Authors.

Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW.

J Urol. 2020 Jan 17:101097JU000000000000062102. doi: 10.1097/JU.0000000000000621.02. [Epub ahead of print] No abstract available.

PMID:
31951502
3.

Distance Dependence of Electronic Coupling in Rigid, Cofacially Compressed, π-Stacked Organic Mixed-Valence Systems.

Jung HW, Yoon SE, Carroll PJ, Gau MR, Therien MJ, Kang YK.

J Phys Chem B. 2020 Feb 13;124(6):1033-1048. doi: 10.1021/acs.jpcb.9b09578. Epub 2020 Jan 28.

PMID:
31927963
4.

The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.

Lafita-Navarro MC, Liaño-Pons J, Quintanilla A, Varela I, Blanco R, Ourique F, Bretones G, Aresti J, Molina E, Carroll P, Hurlin P, Romero OA, Sanchez-Céspedes M, Eisenman RN, Delgado MD, León J.

J Biol Chem. 2020 Feb 14;295(7):2001-2017. doi: 10.1074/jbc.RA119.010389. Epub 2020 Jan 9.

PMID:
31919096
5.

Intravenous epinephrine overdose in prehospital management of suspected anaphylaxis.

Callum J, Rivlin M, Carroll P.

BMJ Case Rep. 2020 Jan 8;13(1). pii: e232654. doi: 10.1136/bcr-2019-232654.

PMID:
31919066
6.

MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort.

Washington SL 3rd, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR.

AJR Am J Roentgenol. 2020 Jan 8:1-5. doi: 10.2214/AJR.19.21559. [Epub ahead of print]

PMID:
31913068
7.

Neurog2 Deficiency Uncovers a Critical Period of Cell Fate Plasticity and Vulnerability among Neural-Crest-Derived Somatosensory Progenitors.

Ventéo S, Desiderio S, Cabochette P, Deslys A, Carroll P, Pattyn A.

Cell Rep. 2019 Dec 3;29(10):2953-2960.e2. doi: 10.1016/j.celrep.2019.11.002.

8.

Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.

Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS.

Clin Genitourin Cancer. 2020 Feb;18(1):e21-e27. doi: 10.1016/j.clgc.2019.10.026. Epub 2019 Nov 6.

PMID:
31796344
9.

Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.

Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR.

Cancer Med. 2020 Jan;9(1):125-132. doi: 10.1002/cam4.2685. Epub 2019 Nov 12.

10.

African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study (PASS).

Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW.

J Urol. 2019 Oct 25:101097JU0000000000000621. doi: 10.1097/JU.0000000000000621. [Epub ahead of print]

PMID:
31651227
11.

Correction: Synthesis of novel copper-rare earth BINOLate frameworks from a hydrogen bonding DBU-H rare earth BINOLate complex.

Panetti GB, Robinson JR, Carroll PJ, Gau MR, Manor BC, Walsh PJ, Schelter EJ.

Dalton Trans. 2019 Nov 21;48(43):16460. doi: 10.1039/c9dt90225b. Epub 2019 Oct 24.

PMID:
31647082
12.

Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.

Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B.

J Urol. 2019 Oct 23:101097JU0000000000000617. doi: 10.1097/JU.0000000000000617. [Epub ahead of print]

PMID:
31642740
13.

A GABAergic Maf-expressing interneuron subset regulates the speed of locomotion in Drosophila.

Babski H, Jovanic T, Surel C, Yoshikawa S, Zwart MF, Valmier J, Thomas JB, Enriquez J, Carroll P, Garcès A.

Nat Commun. 2019 Oct 22;10(1):4796. doi: 10.1038/s41467-019-12693-6.

14.

Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts.

Lange JM, Laviana AA, Penson DF, Lin DW, Bill-Axelson A, Carlsson SV, Newcomb LF, Trock BJ, Carter HB, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Etzioni RB.

Cancer. 2020 Feb 1;126(3):583-592. doi: 10.1002/cncr.32557. Epub 2019 Oct 22.

PMID:
31639200
15.

Germline testing in those at risk of prostate cancer.

Carroll PR, Witte JS, Parsons JK.

Can J Urol. 2019 Oct;26(5S2):31-33.

16.

Access to Highly Functionalized Cyclopentenones via Diastereoselective Pauson-Khand Reaction of Siloxy-Tethered 1,7-Enynes.

Gallagher AG, Tian H, Torres-Herrera OA, Yin S, Xie A, Lange DM, Wilson JK, Mueller LG, Gau MR, Carroll PJ, Martinez-Solorio D.

Org Lett. 2019 Nov 1;21(21):8646-8651. doi: 10.1021/acs.orglett.9b03255. Epub 2019 Oct 15.

PMID:
31613103
17.

Magnetic Field Directed Rare-Earth Separations.

Higgins RF, Cheisson T, Cole BE, Manor BC, Carroll PJ, Schelter EJ.

Angew Chem Int Ed Engl. 2020 Jan 27;59(5):1851-1856. doi: 10.1002/anie.201911606. Epub 2019 Dec 12.

PMID:
31610094
18.

Interdependent Metal-Metal Bonding and Ligand Redox-Activity in a Series of Dinuclear Macrocyclic Complexes of Iron, Cobalt, and Nickel.

Wang Q, Zhang S, Cui P, Weberg AB, Thierer LM, Manor BC, Gau MR, Carroll PJ, Tomson NC.

Inorg Chem. 2019 Oct 5. doi: 10.1021/acs.inorgchem.9b02339. [Epub ahead of print]

PMID:
31587561
19.

'A level playing field': Young people's experiences of wheelchair basketball as an enabling place.

Bates L, Kearns R, Witten K, Carroll P.

Health Place. 2019 Nov;60:102192. doi: 10.1016/j.healthplace.2019.102192. Epub 2019 Sep 18.

PMID:
31541720
20.

Using Benchmarking Standards to Evaluate Transition to Minimally Invasive Esophagectomy.

Carroll PA, Jacob N, Yeung JC, Darling GE.

Ann Thorac Surg. 2020 Feb;109(2):383-388. doi: 10.1016/j.athoracsur.2019.08.019. Epub 2019 Sep 18.

PMID:
31541632
21.

Practical Aspects of Introduction of Multiplex Bead Technology into the Routine Diagnostic Immunology Laboratory.

Swana G, Kariyawasam D, Carroll P, Karim MY.

Clin Lab. 2019 Sep 1;65(9). doi: 10.7754/Clin.Lab.2019.190147.

PMID:
31532090
22.

Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.

Weinstock C, Suzman D, Kluetz P, Baxley J, Viviano C, Ibrahim A, Jarow J, Sridhara R, Liu K, Carroll P, Eggener S, Hu JC, Hussain M, King M, Klein E, Kungel T, Makarov D, Pinto PA, Rini B, Roach M, Sandler H, Schlegel PN, Song D, Goldberg K, Pazdur R, Beaver JA.

J Urol. 2020 Jan;203(1):115-119. doi: 10.1097/JU.0000000000000532. Epub 2019 Sep 10.

PMID:
31502940
23.

Imaging Features of Succinate Dehydrogenase-deficient Pheochromocytoma-Paraganglioma Syndromes.

Withey SJ, Perrio S, Christodoulou D, Izatt L, Carroll P, Velusamy A, Obholzer R, Lewington V, Jacques AET.

Radiographics. 2019 Sep-Oct;39(5):1393-1410. doi: 10.1148/rg.2019180151.

PMID:
31498738
24.

Halide anion discrimination by a tripodal hydroxylamine ligand in gas and condensed phases.

Cheisson T, Jian J, Su J, Eaton TM, Gau MR, Carroll PJ, Batista ER, Yang P, Gibson JK, Schelter EJ.

Phys Chem Chem Phys. 2019 Sep 18;21(36):19868-19878. doi: 10.1039/c9cp03764k.

PMID:
31475264
25.

Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.

Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM.

Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1917-1925. doi: 10.1158/1055-9965.EPI-19-0488. Epub 2019 Aug 28.

PMID:
31462398
26.

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.

Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR.

Prostate Cancer Prostatic Dis. 2020 Mar;23(1):136-143. doi: 10.1038/s41391-019-0167-9. Epub 2019 Aug 27.

PMID:
31455846
27.

Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts.

Drost FH, Nieboer D, Morgan TM, Carroll PR, Roobol MJ; Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP) Consortium.

Eur Urol. 2019 Nov;76(5):693-702. doi: 10.1016/j.eururo.2019.07.041. Epub 2019 Aug 24.

PMID:
31451332
28.

Tuning Metal-Metal Interactions through Reversible Ligand Folding in a Series of Dinuclear Iron Complexes.

Zhang S, Wang Q, Thierer LM, Weberg AB, Gau MR, Carroll PJ, Tomson NC.

Inorg Chem. 2019 Sep 16;58(18):12234-12244. doi: 10.1021/acs.inorgchem.9b01673. Epub 2019 Aug 26.

PMID:
31448589
29.

Active surveillance for intermediate-risk prostate cancer: yes, but for whom?

Overland MR, Washington SL 3rd, Carroll PR, Cooperberg MR, Herlemann A.

Curr Opin Urol. 2019 Nov;29(6):605-611. doi: 10.1097/MOU.0000000000000671.

PMID:
31436567
30.

A Transannular Rearrangement Reaction of a Pyrroloindoline Diketopiperazine.

Yan Q, Carroll PJ, Gau MR, Winkler JD, Joullié MM.

Org Lett. 2019 Aug 15. doi: 10.1021/acs.orglett.9b02084. [Epub ahead of print]

PMID:
31414824
31.

Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer.

Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M 3rd, Hope TA, Carroll PR, Feng FY.

Eur Urol Oncol. 2019 Nov;2(6):685-690. doi: 10.1016/j.euo.2018.11.002. Epub 2019 Jan 15.

PMID:
31411984
32.

Interventions to prevent iatrogenic anemia: a Laboratory Medicine Best Practices systematic review.

Whitehead NS, Williams LO, Meleth S, Kennedy SM, Ubaka-Blackmoore N, Geaghan SM, Nichols JH, Carroll P, McEvoy MT, Gayken J, Ernst DJ, Litwin C, Epner P, Taylor J, Graber ML.

Crit Care. 2019 Aug 9;23(1):278. doi: 10.1186/s13054-019-2511-9.

33.

Guidelines should be assessed based on the underlying evidence.

Carroll PR, Parsons JK.

CMAJ. 2019 Aug 6;191(31):E871. doi: 10.1503/cmaj.72508. No abstract available.

PMID:
31387962
34.

Characterization of the simplest hydroperoxide ester, hydroperoxymethyl formate, a precursor of atmospheric aerosols.

Porterfield JP, Lee KLK, Dell'Isola V, Carroll PB, McCarthy MC.

Phys Chem Chem Phys. 2019 Aug 21;21(33):18065-18070. doi: 10.1039/c9cp03466h.

PMID:
31378792
35.

Reply by Authors.

Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC.

J Urol. 2019 Nov;202(5):958. doi: 10.1097/01.JU.0000579312.61159.39. Epub 2019 Oct 9. No abstract available.

PMID:
31364932
36.

Hematuria Practice Guidelines That Explicitly Consider Harms and Costs.

Bauer SR, Carroll PR, Grady D.

JAMA Intern Med. 2019 Jul 29. doi: 10.1001/jamainternmed.2019.2269. [Epub ahead of print] No abstract available.

PMID:
31355847
37.

Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.

Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR.

Eur Urol. 2019 Dec;76(6):743-751. doi: 10.1016/j.eururo.2019.07.012. Epub 2019 Jul 23.

PMID:
31345635
38.

Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research.

Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL 3rd, Herlemann A, Carroll PR, Cooperberg MR.

JCO Clin Cancer Inform. 2019 Jul;3:1-8. doi: 10.1200/CCI.18.00084.

39.

Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer.

Friedlander TW, Welty C, Anantharaman A, Schonhoft JD, Jendrisak A, Lee J, Li P, Hough J, Stromlund A, Edwards M, Sangar S, Kobayashi Y, Simko J, Farrokhian N, Lindquist K, Greene S, Ontiveros P, Graf R, Rodriquez A, Suraneni M, Wang Y, Landers M, Carroll P, Cooperberg MR, Dittamore R, Paris PL.

J Urol. 2019 Oct;202(4):732-741. doi: 10.1097/JU.0000000000000393. Epub 2019 Sep 6.

PMID:
31216253
40.

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.

van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, Hyndman E, Moore CM, Gnanapragasam V, Van Hemelrijck M, Dasgupta P, Bangma C, Roobol M, Villers A, Rannikko A, Valdagni R, Perry A, Hugosson J, Rubio-Briones J, Bjartell A, Hefermehl L, Shiong LL, Frydenberg M, Kakehi Y, Chung BH, van der Kwast T, Obbink H, van der Linden W, Hulsen T, de Jonge C, Kattan M, Xinge J, Muir K, Lophatananon A, Fahey M, Steyerberg E, Nieboer D, Zhang L, Guo W, Benfante N, Cowan J, Patil D, Tolosa E, Kim TK, Mamedov A, LaPointe V, Crump T, Kimberly-Duffell J, Santaolalla A, Nieboer D, Olivier JT, Rancati T, Ahlgren H, Mascarós J, Löfgren A, Lehmann K, Lin CH, Hirama H, Lee KS, Jenster G, Auvinen A, Bjartell A, Haider M, van Bochove K, Carter B, Gledhill S, Buzza M, Bangma C, Roobol M, Bruinsma S, Helleman J.

Eur Urol Oncol. 2019 May;2(3):333-336. doi: 10.1016/j.euo.2018.08.017. Epub 2018 Sep 13.

PMID:
31200849
41.

A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study.

Balakrishnan AS, Nguyen HG, Shinohara K, Au Yeung R, Carroll PR, Odisho AY.

J Med Internet Res. 2019 Jun 2;21(6):e14094. doi: 10.2196/14094.

42.

Redox-Driven Chelation and Kinetic Separation of Select Rare Earths Using a Tripodal Nitroxide Proligand.

Cole BE, Cheisson T, Higgins RF, Nakamaru-Ogiso E, Manor BC, Carroll PJ, Schelter EJ.

Inorg Chem. 2020 Jan 6;59(1):172-178. doi: 10.1021/acs.inorgchem.9b00975. Epub 2019 Jun 14.

PMID:
31199139
43.

The impact of a gender-specific physical activity intervention on the fitness and fatness profile of men in Ireland.

Kelly L, Harrison M, Richardson N, Carroll P, Robertson S, Keohane A, Donohoe A.

Eur J Public Health. 2019 Dec 1;29(6):1154-1160. doi: 10.1093/eurpub/ckz100.

PMID:
31168620
44.

Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.

Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR.

Eur Urol Oncol. 2018 Oct;1(5):386-394. doi: 10.1016/j.euo.2018.04.018. Epub 2018 May 24.

PMID:
31158077
45.

Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor.

Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR.

Urology. 2019 Sep;131:157-165. doi: 10.1016/j.urology.2019.05.018. Epub 2019 May 28.

PMID:
31150694
46.

SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.

Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR, Viviano CJ, Wysock JS, Hu JC.

J Urol. 2019 Nov;202(5):952-958. doi: 10.1097/JU.0000000000000357. Epub 2019 Oct 9.

PMID:
31144591
47.

Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions.

Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR.

Int Braz J Urol. 2019 Jul-Aug;45(4):713-723. doi: 10.1590/S1677-5538.IBJU.2018.0768.

48.

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.

Cooperberg MR, Carroll PR, Dall'Era MA, Davies BJ, Davis JW, Eggener SE, Feng FY, Lin DW, Morgan TM, Morgans AK, Spratt DE, Taneja SS, Penson DF.

Eur Urol. 2019 Sep;76(3):268-272. doi: 10.1016/j.eururo.2019.05.013. Epub 2019 May 23.

PMID:
31128968
49.

Multiple Bonding in Lanthanides and Actinides: Direct Comparison of Covalency in Thorium(IV)- and Cerium(IV)-Imido Complexes.

Cheisson T, Kersey KD, Mahieu N, McSkimming A, Gau MR, Carroll PJ, Schelter EJ.

J Am Chem Soc. 2019 Jun 12;141(23):9185-9190. doi: 10.1021/jacs.9b04061. Epub 2019 Jun 3.

PMID:
31117665
50.

Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.

Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T.

Eur Urol Oncol. 2018 May;1(1):78-82. doi: 10.1016/j.euo.2018.03.010. Epub 2018 May 15.

PMID:
31100231

Supplemental Content

Loading ...
Support Center